Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Harry Janssen, Prof
Woman and Man Max 99 years
Harry Janssen, Prof
Update Il y a 4 ans
Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
This is a prospective randomized, open-label, phase IV clinical trial to learn the effects, good and/or bad, of discontinuing or continuing nucleos(t)ide analogue (NA) treatment for 72 wee...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Harry Janssen, Prof. dr
Update Il y a 4 ans
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B
The purpose of this study is to investigate whether it is possible to augment the response of patients with HBeAg-positive chronic hepatitis B to entecavir by using a temporary peginterfer...
Country
China
,
Netherlands
,
Poland
,
Romania
,
Turkey
organs
None
Specialty
None
Closed trial
More information